Condition

Posterior Reversible Encephalopathy Syndrome

ClinicalTrials.gov condition label

Clinical trials7

Recruiting1

Common interventions7

Lead sponsors shown4

Clinical trials

7 shown

Posterior Reversible Encephalopathy Syndrome in the Critically Ill PatientsNCT03470467 · 2018-03-09

Inflammatory Biomarkers for the Diagnosis of oPRESNCT05433870 · 2022-07-01

Copeptin Kinetics in Critically Ill Patients With Posterior Reversible Encephalopathy SyndromeNCT04950270 · 2022-06-18

The Predictors of ICU Admission of oPRESNCT05310513 · 2022-04-01

Long-term Consequences of Neuroimaging and Perceived Cognitive Dysfunction in oPRESNCT05140850 · 2022-01-01

The Clinical and Prognostic Features of PRESNCT05143710 · 2020-10-01

Prognostic Observation of Posterior Reversible Encephalopathy SyndromeNCT02665598 · 2016-04-01

Common interventions

Blood copeptin monitoringBIOLOGICAL1 neuroimaging examination,neuro-cognitive test,blood pressure,blood sampleBIOLOGICAL1 No interventionOTHER1 phone interviewOTHER1 PRES in PE or EDIAGNOSTIC_TEST1 Whether the patient needs to be admitted to the ICUOTHER1 Whether the PE or E patient combined with PRESOTHER1

Leading sponsors

Dunjin Chen4 Ictal Group1 University Hospital, Tours1 Yantai Yuhuangding Hospital1

Trial status mix

COMPLETED4

UNKNOWN2

RECRUITING1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.